Bart Biesmans
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
-
- Genetic factors in colorectal cancer
Papers in
- Oncology 15
- Colorectal Cancer Treatments and Studies 14
- Cancer Treatment and Pharmacology 2
- Peptidase Inhibition and Analysis 1
-
- Genetic factors in colorectal cancer 5
- Co-authors
- Sabine Tejpar (11 shared papers)Eric Van Cutsem (7 shared papers)Wendy De Roock (9 shared papers)Hubert Piessevaux (4 shared papers)Yves Humblet (4 shared papers)Marc Peeters (4 shared papers)Gert De Hertogh (3 shared papers)Nicola Personeni (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Annals of Oncology (2 papers)Clinical Cancer Research (2 papers)Journal of Molecular Diagnostics (2 papers)BioMed Research International (1 paper)
- Partner nations
- BelgiumSwitzerlandFrance
In The Last Decade
Bart Biesmans
16 papers receiving 4.3k citations
Bart Biesmans's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 3.2k
- Pathology and Forensic Medicine 1.4k
- Cancer Research 790
- Hepatology 404
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Bart Biesmans
This map shows the geographic impact of Bart Biesmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Biesmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Biesmans more than expected).
Fields of papers citing papers by Bart Biesmans
This network shows the impact of papers produced by Bart Biesmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Biesmans. The network helps show where Bart Biesmans may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Biesmans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis Hit paper breakdown → | 2010 | 1811 |
| 2 | Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial Hit paper breakdown → | 2009 | 989 |
| 3 | KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab Hit paper breakdown → | 2007 | 728 |
| 4 | 2009 | 300 | |
| 5 | 2009 | 253 | |
| 6 | 2008 | 140 | |
| 7 | 2009 | 72 | |
| 8 | 2009 | 38 | |
| 9 | 2012 | 26 | |
| 10 | 2013 | 21 | |
| 11 | 2012 | 13 | |
| 12 | Correlation of high amphiregulin and epiregulin expression in KRAS wild type colorectal primaries with response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease. | 2008 | 12 |
| 13 | 2012 | 10 | |
| 14 | 2015 | 3 | |
| 15 | PIK3CA mutations do not confer resistance to the EGFR-inhibitor cetuximab in chemorefractory metastatic colorectal cancer | 2009 | 1 |
| 16 | 2012 | 1 |
About Bart Biesmans
Bart Biesmans is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 16 papers that have together received 4.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Genetic factors in colorectal cancer (5 papers), Gastric Cancer Management and Outcomes (2 papers), Cancer Treatment and Pharmacology (2 papers), Lung Cancer Treatments and Mutations (2 papers), Multiple and Secondary Primary Cancers (1 paper), Cancer Genomics and Diagnostics (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (3.2k citations), Pathology and Forensic Medicine (1.4k citations), Cancer Research (790 citations), Hepatology (404 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Bart Biesmans has collaborated with scholars based in Belgium, Switzerland and France. Frequent co-authors include Sabine Tejpar, Eric Van Cutsem, Wendy De Roock, Hubert Piessevaux, Yves Humblet, Marc Peeters, Gert De Hertogh, Nicola Personeni, Jef De Schutter and Joris De Schutter. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Journal of Molecular Diagnostics and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.